Opportunity
DIBBS #SPE2DP-26-T-2619
DLA Procurement of Guaifenesin Extended-Release Tablets for Fort Bragg
Posted
April 03, 2026
Respond By
April 08, 2026
Identifier
SPE2DP-26-T-2619
NAICS
424210
This opportunity involves the Defense Logistics Agency Troop Support Medical Supply Chain Pharmacy FSA seeking Guaifenesin Extended-Release Tablets for military use. - Government Buyer: - Defense Logistics Agency (DLA) - Sub-agency: DLA Troop Support Medical Supply Chain Pharmacy FSA - Office: Buyer Code DMK0005 - OEMs (Original Equipment Manufacturers): - Reckitt Benckiser LLC (NDC63824-0008-50) - The Harvard Drug Group, L.L.C. (NDC00904-6986-04) - Products Requested: - Guaifenesin Extended-Release Tablets, 600mg, bottles of 500 tablets - NSN: 6505-01-340-5446 / 6505013405446 - Quantity: 25 bottles - Notable Requirements: - Packaging and marking must comply with Medical Marking Standard No. 1 and MIL-STD-2073-1E - Shelf life of 36 months with at least 31 months remaining at delivery - Hazardous material labeling and FDA regulation compliance required - Domestic sourcing requirements apply - Delivery Location: - Fort Bragg, NC (3D SFG SSA AWCF SSF unit) - Delivery required within 20 days FOB destination
Description
GUAIFENESIN EXTENDE (QTY: 25, NSN: 6505-01-340-5446, Purchase Request: 7016171686) Approved Sources: - CAGE: 0MWS8, Part No: NDC63824-0008-50, Company: RECKITT BENCKISER LLC - CAGE: 1LEZ0, Part No: NDC00904-6986-04, Company: THE HARVARD DRUG GROUP, L.L.C.